Scope and limitations of therapy with plasma substitutes: differential indication for substitutes, blood preparations and electrolyte solutions.
D000059:Accidents; D000368:Aged; D001778:Blood Coagulation Disorders / Q000628:therapy; D001803:Blood Transfusion; D002056:Burns / Q000628:therapy; D003911:Dextrans / Q000627:therapeutic use; D004487:Edema / Q000628:therapy; D004573:Electrolytes / Q000627:therapeutic use*; D005112:Extracorporeal Circulation; D005392:First Aid; D005780:Gelatin / Q000627:therapeutic use; D006801:Humans; D007674:Kidney Diseases / Q000628:therapy; D008970:Molecular Weight; D010952:Plasma Substitutes / Q000627:therapeutic use*; D012771:Shock, Hemorrhagic / Q000175:diagnosis / Q000503:physiopathology / Q000517:prevention & control*; D012773:Shock, Surgical; D013514:Surgical Procedures, Operative; D013927:Thrombosis / Q000628:therapy
D003911:Dextrans; D004573:Electrolytes; D010952:Plasma Substitutes; D005780:Gelatin